

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 6.23818908 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 6.23818908 |
| 3 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.58670411 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.24850709 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.24850709 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 4.22550785 |
| 7 | response to peptidoglycan (GO:0032494) | 4.16737270 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 3.99334672 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.99334672 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.99334672 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.99334672 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.99334672 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.99334672 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.99049259 |
| 15 | germinal center formation (GO:0002467) | 3.93329226 |
| 16 | myelination (GO:0042552) | 3.89000206 |
| 17 | ensheathment of neurons (GO:0007272) | 3.88344754 |
| 18 | axon ensheathment (GO:0008366) | 3.88344754 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.83382388 |
| 20 | detection of other organism (GO:0098543) | 3.78336692 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.75205502 |
| 22 | cellular extravasation (GO:0045123) | 3.70867487 |
| 23 | tolerance induction (GO:0002507) | 3.63538601 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.58826847 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57488854 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47673608 |
| 27 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.47360241 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.44745522 |
| 29 | fatty acid elongation (GO:0030497) | 3.40821626 |
| 30 | neutrophil mediated immunity (GO:0002446) | 3.38971162 |
| 31 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.34112509 |
| 32 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.32651839 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.32359029 |
| 34 | type I interferon signaling pathway (GO:0060337) | 3.32359029 |
| 35 | microglial cell activation (GO:0001774) | 3.29677216 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.29176335 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.29086581 |
| 38 | detection of bacterium (GO:0016045) | 3.27870093 |
| 39 | response to type I interferon (GO:0034340) | 3.26953678 |
| 40 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.26525836 |
| 41 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.26525836 |
| 42 | macrophage activation (GO:0042116) | 3.26138268 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.22739508 |
| 44 | response to protozoan (GO:0001562) | 3.15845549 |
| 45 | neutrophil activation involved in immune response (GO:0002283) | 3.14585012 |
| 46 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.10986705 |
| 47 | negative regulation of neurotransmitter transport (GO:0051589) | 3.10384040 |
| 48 | regulation of interferon-alpha production (GO:0032647) | 3.08940384 |
| 49 | detection of biotic stimulus (GO:0009595) | 3.08381932 |
| 50 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.08094974 |
| 51 | virion attachment to host cell (GO:0019062) | 3.06484395 |
| 52 | adhesion of symbiont to host cell (GO:0044650) | 3.06484395 |
| 53 | regulation of germinal center formation (GO:0002634) | 3.04981155 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04737029 |
| 55 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.03150078 |
| 56 | response to interleukin-15 (GO:0070672) | 3.02712116 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.02288915 |
| 58 | positive regulation of heat generation (GO:0031652) | 3.01972990 |
| 59 | positive regulation of interleukin-17 production (GO:0032740) | 3.01966928 |
| 60 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01000887 |
| 61 | positive regulation of interferon-alpha production (GO:0032727) | 2.97919048 |
| 62 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.97383200 |
| 63 | presynaptic membrane assembly (GO:0097105) | 2.96341841 |
| 64 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.96231040 |
| 65 | presynaptic membrane organization (GO:0097090) | 2.95229534 |
| 66 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94214857 |
| 67 | myelin maintenance (GO:0043217) | 2.93726292 |
| 68 | T cell migration (GO:0072678) | 2.93296904 |
| 69 | myeloid leukocyte mediated immunity (GO:0002444) | 2.92138731 |
| 70 | membrane raft organization (GO:0031579) | 2.90348868 |
| 71 | response to muramyl dipeptide (GO:0032495) | 2.89318663 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88699370 |
| 73 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.86055744 |
| 74 | interferon-gamma production (GO:0032609) | 2.86003451 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 2.85693457 |
| 76 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.85222826 |
| 77 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84588122 |
| 78 | cellular response to interleukin-15 (GO:0071350) | 2.84394638 |
| 79 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.83922817 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 2.83635452 |
| 81 | Rap protein signal transduction (GO:0032486) | 2.83109219 |
| 82 | regulation of type 2 immune response (GO:0002828) | 2.82602827 |
| 83 | regulation of interleukin-12 production (GO:0032655) | 2.81466716 |
| 84 | oligodendrocyte differentiation (GO:0048709) | 2.80575697 |
| 85 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.80205098 |
| 86 | positive regulation of antigen processing and presentation (GO:0002579) | 2.79347564 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79226762 |
| 88 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.78721595 |
| 89 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.78690535 |
| 90 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.78212456 |
| 91 | L-amino acid import (GO:0043092) | 2.78173304 |
| 92 | response to host immune response (GO:0052572) | 2.76366489 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76366489 |
| 94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.75463199 |
| 95 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.74151188 |
| 96 | membrane assembly (GO:0071709) | 2.72070321 |
| 97 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72010490 |
| 98 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.71082487 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 2.69965209 |
| 100 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.69644901 |
| 101 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.67546316 |
| 102 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.67403711 |
| 103 | negative thymic T cell selection (GO:0045060) | 2.66898344 |
| 104 | positive regulation of acute inflammatory response (GO:0002675) | 2.66141498 |
| 105 | nerve growth factor signaling pathway (GO:0038180) | 2.65575785 |
| 106 | response to lipoprotein particle (GO:0055094) | 2.63966980 |
| 107 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.63352563 |
| 108 | regulation of memory T cell differentiation (GO:0043380) | 2.61774881 |
| 109 | T-helper 1 type immune response (GO:0042088) | 2.60185378 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.59669461 |
| 111 | regulation of interleukin-17 production (GO:0032660) | 2.58643303 |
| 112 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.56960421 |
| 113 | photoreceptor cell differentiation (GO:0046530) | 2.55017027 |
| 114 | eye photoreceptor cell differentiation (GO:0001754) | 2.55017027 |
| 115 | neutrophil activation (GO:0042119) | 2.54981909 |
| 116 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.51091295 |
| 117 | mast cell activation (GO:0045576) | 2.49869291 |
| 118 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.48047721 |
| 119 | creatine metabolic process (GO:0006600) | 2.47138269 |
| 120 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.46457963 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.45143328 |
| 122 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.43859353 |
| 123 | growth hormone receptor signaling pathway (GO:0060396) | 2.43464415 |
| 124 | adhesion of symbiont to host (GO:0044406) | 2.40738358 |
| 125 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.39735824 |
| 126 | granulocyte activation (GO:0036230) | 2.39454320 |
| 127 | regulation of T-helper cell differentiation (GO:0045622) | 2.39006965 |
| 128 | membrane tubulation (GO:0097320) | 2.38935042 |
| 129 | regulation of activation of Janus kinase activity (GO:0010533) | 2.38438930 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 2.38136864 |
| 131 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.37511133 |
| 132 | positive regulation of T cell cytokine production (GO:0002726) | 2.33954460 |
| 133 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.31824415 |
| 134 | glycosylceramide metabolic process (GO:0006677) | 2.30275171 |
| 135 | positive regulation of type 2 immune response (GO:0002830) | 2.29217900 |
| 136 | amino acid import (GO:0043090) | 2.27967259 |
| 137 | positive regulation of glial cell differentiation (GO:0045687) | 2.27885605 |
| 138 | negative regulation of protein localization to cell surface (GO:2000009) | 2.27051333 |
| 139 | negative regulation of interleukin-10 production (GO:0032693) | 2.25396068 |
| 140 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.24945364 |
| 141 | positive regulation of pseudopodium assembly (GO:0031274) | 2.22179945 |
| 142 | positive regulation of astrocyte differentiation (GO:0048711) | 2.20694877 |
| 143 | positive regulation of lipid kinase activity (GO:0090218) | 2.19573932 |
| 144 | positive regulation of interleukin-12 production (GO:0032735) | 2.19343576 |
| 145 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.18487279 |
| 146 | regulation of heat generation (GO:0031650) | 2.18267980 |
| 147 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.17777529 |
| 148 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.16218057 |
| 149 | * positive regulation of interleukin-2 production (GO:0032743) | 2.15807338 |
| 150 | neuron remodeling (GO:0016322) | 2.15503220 |
| 151 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.14920503 |
| 152 | import into cell (GO:0098657) | 2.13387921 |
| 153 | mast cell degranulation (GO:0043303) | 2.12495659 |
| 154 | mast cell activation involved in immune response (GO:0002279) | 2.12495659 |
| 155 | myeloid cell activation involved in immune response (GO:0002275) | 2.12411336 |
| 156 | positive regulation of gliogenesis (GO:0014015) | 2.12115515 |
| 157 | positive regulation of interleukin-4 production (GO:0032753) | 2.11679288 |
| 158 | lymphoid progenitor cell differentiation (GO:0002320) | 2.11609810 |
| 159 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.11261685 |
| 160 | regulation of collateral sprouting (GO:0048670) | 2.11088984 |
| 161 | leukocyte aggregation (GO:0070486) | 2.10886915 |
| 162 | astrocyte development (GO:0014002) | 2.10474183 |
| 163 | negative regulation of exocytosis (GO:0045920) | 2.10417528 |
| 164 | regulation of T-helper 1 type immune response (GO:0002825) | 2.10360879 |
| 165 | serine transport (GO:0032329) | 2.09483288 |
| 166 | B cell receptor signaling pathway (GO:0050853) | 2.09389680 |
| 167 | leukocyte degranulation (GO:0043299) | 2.09063240 |
| 168 | amyloid precursor protein metabolic process (GO:0042982) | 2.08605070 |
| 169 | cellular response to growth hormone stimulus (GO:0071378) | 2.08552604 |
| 170 | glycerophospholipid catabolic process (GO:0046475) | 2.07244324 |
| 171 | positive regulation of interleukin-10 production (GO:0032733) | 2.06040674 |
| 172 | regulation of fever generation (GO:0031620) | 2.05528616 |
| 173 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.05237352 |
| 174 | negative regulation of interleukin-17 production (GO:0032700) | 2.05041663 |
| 175 | defense response to protozoan (GO:0042832) | 2.04834355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.85748604 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.25375210 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.04572339 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.47809566 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.37644713 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36819011 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.27927737 |
| 8 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.24016181 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.19531831 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17523440 |
| 11 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.12411631 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.04181086 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.04135050 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95879098 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88567586 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.87956329 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83281520 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81889678 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79479699 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.76477851 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76399470 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.75622769 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74138359 |
| 24 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.72082384 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.70223712 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70161548 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70092170 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69289094 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65167338 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63259110 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61450569 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60709696 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56153947 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54812113 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53670628 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51789090 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50737349 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49997600 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48814950 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47783181 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47172686 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46826523 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46661979 |
| 44 | * MYB_26560356_Chip-Seq_TH1_Human | 1.44975177 |
| 45 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44445905 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44445905 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42750112 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41070793 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40024029 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.40001800 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35199447 |
| 52 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.33901483 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33496162 |
| 54 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33445693 |
| 55 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32980778 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31250303 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30811895 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30512167 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30366894 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29295301 |
| 61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26961311 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26726160 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26726160 |
| 64 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26613213 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26397320 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.26388300 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26002471 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24853973 |
| 69 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.24235647 |
| 70 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.24027314 |
| 71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23739788 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22950606 |
| 73 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20845765 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19782461 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18675313 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18361394 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17189625 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17148308 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16801620 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15554637 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12033335 |
| 82 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.11135895 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10738419 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10570254 |
| 85 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08053141 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07539805 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06234313 |
| 88 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04352372 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01612216 |
| 90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00570235 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00277413 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00198338 |
| 93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.99527469 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98451321 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97755783 |
| 96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97456300 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95434371 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95123534 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94235201 |
| 100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93734794 |
| 101 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93456089 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93311819 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92786137 |
| 104 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91720399 |
| 105 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91411872 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89475742 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89108715 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88635578 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87958785 |
| 110 | MYC_22102868_ChIP-Seq_BL_Human | 0.87719735 |
| 111 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87562776 |
| 112 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87487496 |
| 113 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86796775 |
| 114 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86100780 |
| 115 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85640079 |
| 116 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.85410149 |
| 117 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85170493 |
| 118 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.84696124 |
| 119 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.83754467 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83514638 |
| 121 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.83370123 |
| 122 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83003207 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82406172 |
| 124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.82223470 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81581142 |
| 126 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81443205 |
| 127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81294982 |
| 128 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80951126 |
| 129 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80688099 |
| 130 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.80649177 |
| 131 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80167864 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79755509 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79554560 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79483707 |
| 135 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.79177398 |
| 136 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.79177398 |
| 137 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.79177398 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78990466 |
| 139 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.78822192 |
| 140 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78797657 |
| 141 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78503797 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78452848 |
| 143 | MAF_26560356_Chip-Seq_TH2_Human | 0.78038273 |
| 144 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77874014 |
| 145 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.77839666 |
| 146 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77318617 |
| 147 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.76534627 |
| 148 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76534627 |
| 149 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73607708 |
| 150 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.71729846 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70151372 |
| 152 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.69824207 |
| 153 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.69111260 |
| 154 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68383516 |
| 155 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.67259142 |
| 156 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61757826 |
| 157 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61395424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.68726069 |
| 2 | MP0003724_increased_susceptibility_to | 2.89541953 |
| 3 | MP0004510_myositis | 2.82215623 |
| 4 | MP0003880_abnormal_central_pattern | 2.79481552 |
| 5 | MP0005671_abnormal_response_to | 2.72974983 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.59255680 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.49046633 |
| 8 | MP0009785_altered_susceptibility_to | 2.45936686 |
| 9 | MP0003690_abnormal_glial_cell | 2.35608542 |
| 10 | MP0003950_abnormal_plasma_membrane | 2.35449806 |
| 11 | MP0005387_immune_system_phenotype | 2.35027589 |
| 12 | MP0001790_abnormal_immune_system | 2.35027589 |
| 13 | MP0000685_abnormal_immune_system | 2.26239182 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.22763717 |
| 15 | MP0001851_eye_inflammation | 2.01636368 |
| 16 | MP0004270_analgesia | 2.00471178 |
| 17 | MP0003303_peritoneal_inflammation | 1.99365995 |
| 18 | * MP0002419_abnormal_innate_immunity | 1.96803506 |
| 19 | MP0005025_abnormal_response_to | 1.95670755 |
| 20 | * MP0009764_decreased_sensitivity_to | 1.90672590 |
| 21 | * MP0002723_abnormal_immune_serum | 1.83597001 |
| 22 | MP0005171_absent_coat_pigmentation | 1.81617540 |
| 23 | MP0006082_CNS_inflammation | 1.79426143 |
| 24 | MP0001853_heart_inflammation | 1.77240920 |
| 25 | MP0004742_abnormal_vestibular_system | 1.75599056 |
| 26 | MP0001800_abnormal_humoral_immune | 1.75375827 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.74778328 |
| 28 | MP0005409_darkened_coat_color | 1.72353198 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.65028909 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.64362227 |
| 31 | MP0003075_altered_response_to | 1.59239129 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.58345429 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.58345429 |
| 34 | * MP0002420_abnormal_adaptive_immunity | 1.57322103 |
| 35 | MP0004147_increased_porphyrin_level | 1.56978586 |
| 36 | MP0001486_abnormal_startle_reflex | 1.56797894 |
| 37 | * MP0001819_abnormal_immune_cell | 1.56062710 |
| 38 | MP0002272_abnormal_nervous_system | 1.51407960 |
| 39 | MP0002064_seizures | 1.51027741 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.49200568 |
| 41 | MP0008004_abnormal_stomach_pH | 1.47865195 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.47737983 |
| 43 | MP0001905_abnormal_dopamine_level | 1.47148823 |
| 44 | MP0009745_abnormal_behavioral_response | 1.46956587 |
| 45 | MP0005310_abnormal_salivary_gland | 1.46920158 |
| 46 | MP0002254_reproductive_system_inflammat | 1.39338447 |
| 47 | MP0005166_decreased_susceptibility_to | 1.36094522 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.34372666 |
| 49 | MP0004885_abnormal_endolymph | 1.33172403 |
| 50 | MP0003436_decreased_susceptibility_to | 1.29643775 |
| 51 | MP0003634_abnormal_glial_cell | 1.28840234 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.28382833 |
| 53 | MP0009046_muscle_twitch | 1.27574922 |
| 54 | MP0008569_lethality_at_weaning | 1.24875713 |
| 55 | MP0003329_amyloid_beta_deposits | 1.23329388 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 1.23201076 |
| 57 | MP0003828_pulmonary_edema | 1.23101792 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.22063987 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.21911630 |
| 60 | MP0002933_joint_inflammation | 1.20345635 |
| 61 | MP0008469_abnormal_protein_level | 1.18225594 |
| 62 | MP0002405_respiratory_system_inflammati | 1.18157572 |
| 63 | MP0002429_abnormal_blood_cell | 1.18020458 |
| 64 | MP0002722_abnormal_immune_system | 1.17783468 |
| 65 | MP0000604_amyloidosis | 1.14312072 |
| 66 | MP0003045_fibrosis | 1.13866789 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.13382372 |
| 68 | MP0009278_abnormal_bone_marrow | 1.13031315 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.12728986 |
| 70 | MP0004142_abnormal_muscle_tone | 1.11586930 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.11355921 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.10934173 |
| 73 | MP0000716_abnormal_immune_system | 1.10925023 |
| 74 | MP0008260_abnormal_autophagy | 1.10399754 |
| 75 | MP0001346_abnormal_lacrimal_gland | 1.10392604 |
| 76 | MP0001502_abnormal_circadian_rhythm | 1.09550317 |
| 77 | MP0000383_abnormal_hair_follicle | 1.09161695 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.09155781 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.06885673 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.05483192 |
| 81 | MP0003448_altered_tumor_morphology | 1.05351706 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 1.04548264 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.03790275 |
| 84 | MP0004381_abnormal_hair_follicle | 1.03578500 |
| 85 | MP0002166_altered_tumor_susceptibility | 1.03038311 |
| 86 | MP0004947_skin_inflammation | 1.02204966 |
| 87 | MP0003136_yellow_coat_color | 1.01057828 |
| 88 | MP0003866_abnormal_defecation | 1.00590412 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 1.00485105 |
| 90 | MP0000703_abnormal_thymus_morphology | 1.00265523 |
| 91 | MP0003633_abnormal_nervous_system | 0.98162188 |
| 92 | MP0002006_tumorigenesis | 0.97919123 |
| 93 | MP0002009_preneoplasia | 0.94435668 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.93666796 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.92916465 |
| 96 | MP0002398_abnormal_bone_marrow | 0.91419822 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.90082833 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.89833475 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.89082364 |
| 100 | MP0001188_hyperpigmentation | 0.88085647 |
| 101 | MP0000249_abnormal_blood_vessel | 0.87786782 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.87360394 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.87350016 |
| 104 | MP0004883_abnormal_blood_vessel | 0.87089568 |
| 105 | MP0002822_catalepsy | 0.86885720 |
| 106 | MP0005390_skeleton_phenotype | 0.86458722 |
| 107 | MP0010352_gastrointestinal_tract_polyps | 0.86388037 |
| 108 | MP0004484_altered_response_of | 0.85329475 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.85145867 |
| 110 | MP0003091_abnormal_cell_migration | 0.84989477 |
| 111 | MP0003631_nervous_system_phenotype | 0.84432470 |
| 112 | MP0002063_abnormal_learning/memory/cond | 0.82601654 |
| 113 | MP0001873_stomach_inflammation | 0.82051082 |
| 114 | MP0008874_decreased_physiological_sensi | 0.81346211 |
| 115 | MP0002229_neurodegeneration | 0.80239293 |
| 116 | MP0005164_abnormal_response_to | 0.80203916 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.78987044 |
| 118 | MP0002572_abnormal_emotion/affect_behav | 0.78968464 |
| 119 | MP0005535_abnormal_body_temperature | 0.78739511 |
| 120 | MP0002735_abnormal_chemical_nociception | 0.77553127 |
| 121 | MP0000343_altered_response_to | 0.77110919 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.77059844 |
| 123 | MP0005174_abnormal_tail_pigmentation | 0.76382604 |
| 124 | MP0002734_abnormal_mechanical_nocicepti | 0.76290528 |
| 125 | MP0009763_increased_sensitivity_to | 0.75709414 |
| 126 | MP0003300_gastrointestinal_ulcer | 0.75687272 |
| 127 | MP0000465_gastrointestinal_hemorrhage | 0.73972580 |
| 128 | MP0001529_abnormal_vocalization | 0.73826794 |
| 129 | MP0002067_abnormal_sensory_capabilities | 0.73190144 |
| 130 | MP0001663_abnormal_digestive_system | 0.72694791 |
| 131 | MP0000858_altered_metastatic_potential | 0.71627801 |
| 132 | MP0003646_muscle_fatigue | 0.65704195 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62746686 |
| 134 | MP0002132_abnormal_respiratory_system | 0.58350934 |
| 135 | MP0006054_spinal_hemorrhage | 0.57633010 |
| 136 | MP0002396_abnormal_hematopoietic_system | 0.53050825 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.52535267 |
| 138 | MP0005451_abnormal_body_composition | 0.48682235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Keratoconjunctivitis sicca (HP:0001097) | 4.35969548 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.27636803 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.16368306 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.16368306 |
| 5 | Parakeratosis (HP:0001036) | 4.08572709 |
| 6 | Keratoconjunctivitis (HP:0001096) | 4.06657491 |
| 7 | Peripheral hypomyelination (HP:0007182) | 3.90349568 |
| 8 | Hemoptysis (HP:0002105) | 3.66630154 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.62775346 |
| 10 | Chronic otitis media (HP:0000389) | 3.57177028 |
| 11 | Stomatitis (HP:0010280) | 3.48424451 |
| 12 | White forelock (HP:0002211) | 3.35459040 |
| 13 | Gangrene (HP:0100758) | 3.32282186 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25178858 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.24770628 |
| 16 | Onion bulb formation (HP:0003383) | 3.24325737 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.16375175 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.15120469 |
| 19 | Encephalitis (HP:0002383) | 3.13880088 |
| 20 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.12393840 |
| 21 | Patchy hypopigmentation of hair (HP:0011365) | 3.09343959 |
| 22 | Chest pain (HP:0100749) | 3.09056236 |
| 23 | Gastrointestinal stroma tumor (HP:0100723) | 3.08239076 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 3.00971423 |
| 25 | Arterial thrombosis (HP:0004420) | 2.99868567 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.99315381 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 2.97743888 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.94428701 |
| 29 | Recurrent skin infections (HP:0001581) | 2.94088654 |
| 30 | Slow saccadic eye movements (HP:0000514) | 2.88264723 |
| 31 | Sensory axonal neuropathy (HP:0003390) | 2.87490788 |
| 32 | Pulmonary embolism (HP:0002204) | 2.83789525 |
| 33 | Abnormality of the pleura (HP:0002103) | 2.82388256 |
| 34 | Abnormality of the corticospinal tract (HP:0002492) | 2.81043021 |
| 35 | Increased IgE level (HP:0003212) | 2.76153459 |
| 36 | Recurrent bronchitis (HP:0002837) | 2.69571478 |
| 37 | Dysmetria (HP:0001310) | 2.66827064 |
| 38 | Episodic fever (HP:0001954) | 2.64006984 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.63731137 |
| 40 | Optic neuritis (HP:0100653) | 2.63731137 |
| 41 | Cerebral hemorrhage (HP:0001342) | 2.60717693 |
| 42 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.58173607 |
| 43 | Hepatosplenomegaly (HP:0001433) | 2.57875366 |
| 44 | Scanning speech (HP:0002168) | 2.57434516 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.56010580 |
| 46 | Intention tremor (HP:0002080) | 2.53396755 |
| 47 | Cellulitis (HP:0100658) | 2.53208121 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.52406187 |
| 49 | Abnormality of T cells (HP:0002843) | 2.52266158 |
| 50 | Myositis (HP:0100614) | 2.51772722 |
| 51 | Vasculitis (HP:0002633) | 2.51333082 |
| 52 | Thickened helices (HP:0000391) | 2.50835798 |
| 53 | Recurrent fungal infections (HP:0002841) | 2.50398339 |
| 54 | Vertigo (HP:0002321) | 2.47769394 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.47152792 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.46988555 |
| 57 | Urticaria (HP:0001025) | 2.46327252 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.43047645 |
| 59 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.42398582 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41389448 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41389448 |
| 62 | Hematochezia (HP:0002573) | 2.38712329 |
| 63 | Focal motor seizures (HP:0011153) | 2.37759593 |
| 64 | Anorexia (HP:0002039) | 2.37617389 |
| 65 | Eosinophilia (HP:0001880) | 2.37612918 |
| 66 | Nonprogressive disorder (HP:0003680) | 2.37159312 |
| 67 | Abnormality of the endocardium (HP:0004306) | 2.35641077 |
| 68 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.33440752 |
| 69 | Abnormal hair whorl (HP:0010721) | 2.31659851 |
| 70 | Keratitis (HP:0000491) | 2.31439841 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30207415 |
| 72 | Hemiplegia (HP:0002301) | 2.28375470 |
| 73 | Alveolar cell carcinoma (HP:0006519) | 2.28328157 |
| 74 | Sepsis (HP:0100806) | 2.26605922 |
| 75 | Orchitis (HP:0100796) | 2.26517451 |
| 76 | Panhypogammaglobulinemia (HP:0003139) | 2.23412610 |
| 77 | Subacute progressive viral hepatitis (HP:0006572) | 2.22906904 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.22687559 |
| 79 | B lymphocytopenia (HP:0010976) | 2.22680270 |
| 80 | Gingivitis (HP:0000230) | 2.21820887 |
| 81 | IgG deficiency (HP:0004315) | 2.21168393 |
| 82 | Polyneuropathy (HP:0001271) | 2.20578717 |
| 83 | Axonal loss (HP:0003447) | 2.19565715 |
| 84 | Papilledema (HP:0001085) | 2.18961725 |
| 85 | Abnormal auditory evoked potentials (HP:0006958) | 2.18674709 |
| 86 | Lymphopenia (HP:0001888) | 2.15152508 |
| 87 | Xerostomia (HP:0000217) | 2.15069098 |
| 88 | Spastic gait (HP:0002064) | 2.15064868 |
| 89 | Widely spaced teeth (HP:0000687) | 2.14977231 |
| 90 | Glomerulopathy (HP:0100820) | 2.14872568 |
| 91 | Purpura (HP:0000979) | 2.10692895 |
| 92 | Granulocytopenia (HP:0001913) | 2.10595812 |
| 93 | Clumsiness (HP:0002312) | 2.09902511 |
| 94 | Restrictive lung disease (HP:0002091) | 2.09602268 |
| 95 | Amyloidosis (HP:0011034) | 2.08496118 |
| 96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07848573 |
| 97 | Pustule (HP:0200039) | 2.06977731 |
| 98 | Inflammation of the large intestine (HP:0002037) | 2.06465445 |
| 99 | Myokymia (HP:0002411) | 2.06295575 |
| 100 | Abnormality of T cell number (HP:0011839) | 2.04115201 |
| 101 | Anhidrosis (HP:0000970) | 2.03109042 |
| 102 | Akinesia (HP:0002304) | 2.02942786 |
| 103 | Loss of speech (HP:0002371) | 2.02049917 |
| 104 | Progressive inability to walk (HP:0002505) | 2.01787979 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.01748802 |
| 106 | Increased cerebral lipofuscin (HP:0011813) | 2.01747185 |
| 107 | Osteomyelitis (HP:0002754) | 2.01645202 |
| 108 | Hypoplasia of the iris (HP:0007676) | 2.00079112 |
| 109 | Disinhibition (HP:0000734) | 1.99761118 |
| 110 | Viral hepatitis (HP:0006562) | 1.99740029 |
| 111 | Premature skin wrinkling (HP:0100678) | 1.98845260 |
| 112 | Colitis (HP:0002583) | 1.98550257 |
| 113 | Depressed nasal tip (HP:0000437) | 1.98061659 |
| 114 | Abnormality of the prostate (HP:0008775) | 1.96933848 |
| 115 | Arthralgia (HP:0002829) | 1.96488538 |
| 116 | Recurrent viral infections (HP:0004429) | 1.95076867 |
| 117 | Weak cry (HP:0001612) | 1.94804742 |
| 118 | Epileptic encephalopathy (HP:0200134) | 1.94788240 |
| 119 | Joint swelling (HP:0001386) | 1.94739054 |
| 120 | Atonic seizures (HP:0010819) | 1.94474519 |
| 121 | Thyroiditis (HP:0100646) | 1.94118341 |
| 122 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93488898 |
| 123 | Meningitis (HP:0001287) | 1.92944904 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 1.92794302 |
| 125 | Memory impairment (HP:0002354) | 1.92697163 |
| 126 | Abnormality of the pericardium (HP:0001697) | 1.91354096 |
| 127 | T lymphocytopenia (HP:0005403) | 1.90969823 |
| 128 | Abnormality of the peritoneum (HP:0002585) | 1.89803499 |
| 129 | Thick nail (HP:0001805) | 1.88939390 |
| 130 | Abnormality of eosinophils (HP:0001879) | 1.87878852 |
| 131 | Ankle clonus (HP:0011448) | 1.86523006 |
| 132 | Pulmonary artery stenosis (HP:0004415) | 1.86425899 |
| 133 | Obstructive lung disease (HP:0006536) | 1.85193673 |
| 134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85193673 |
| 135 | Amaurosis fugax (HP:0100576) | 1.85094544 |
| 136 | Severe combined immunodeficiency (HP:0004430) | 1.84533142 |
| 137 | Stomach cancer (HP:0012126) | 1.84425497 |
| 138 | Interstitial pulmonary disease (HP:0006530) | 1.84349535 |
| 139 | Autoamputation (HP:0001218) | 1.83337022 |
| 140 | Gastrointestinal inflammation (HP:0004386) | 1.82611806 |
| 141 | Difficulty running (HP:0009046) | 1.81352686 |
| 142 | Leukocytosis (HP:0001974) | 1.80664817 |
| 143 | Papilloma (HP:0012740) | 1.80283468 |
| 144 | Verrucae (HP:0200043) | 1.80283468 |
| 145 | Gaze-evoked nystagmus (HP:0000640) | 1.77849927 |
| 146 | Hypergammaglobulinemia (HP:0010702) | 1.76348999 |
| 147 | Increased IgM level (HP:0003496) | 1.75753362 |
| 148 | Conical tooth (HP:0000698) | 1.75277330 |
| 149 | Alacrima (HP:0000522) | 1.74695460 |
| 150 | Recurrent pneumonia (HP:0006532) | 1.74369212 |
| 151 | Abnormality of the periventricular white matter (HP:0002518) | 1.73732601 |
| 152 | Poor speech (HP:0002465) | 1.73606344 |
| 153 | Submucous cleft hard palate (HP:0000176) | 1.72566728 |
| 154 | Broad-based gait (HP:0002136) | 1.72472672 |
| 155 | Lower limb muscle weakness (HP:0007340) | 1.71596796 |
| 156 | Gingival bleeding (HP:0000225) | 1.71355433 |
| 157 | Fatigue (HP:0012378) | 1.71240011 |
| 158 | Abnormality of the columella (HP:0009929) | 1.70637698 |
| 159 | Diplopia (HP:0000651) | 1.68700953 |
| 160 | Abnormality of binocular vision (HP:0011514) | 1.68700953 |
| 161 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68434383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 3.61994657 |
| 2 | STK39 | 3.43161607 |
| 3 | MAP3K14 | 3.02385431 |
| 4 | TNIK | 2.95590078 |
| 5 | OXSR1 | 2.73316574 |
| 6 | RIPK4 | 2.33956339 |
| 7 | CDK19 | 2.25024919 |
| 8 | MAP3K13 | 2.22862275 |
| 9 | IKBKE | 1.95542289 |
| 10 | PKN1 | 1.92226753 |
| 11 | TAOK3 | 1.92124286 |
| 12 | TBK1 | 1.90061442 |
| 13 | MUSK | 1.89876005 |
| 14 | IKBKB | 1.81130869 |
| 15 | MAPKAPK5 | 1.80921055 |
| 16 | NEK6 | 1.80603162 |
| 17 | IRAK4 | 1.73122446 |
| 18 | KIT | 1.65600936 |
| 19 | TXK | 1.58593915 |
| 20 | ZAP70 | 1.57357355 |
| 21 | PRPF4B | 1.54585978 |
| 22 | MST4 | 1.53308950 |
| 23 | PDK2 | 1.49841420 |
| 24 | SIK3 | 1.49799429 |
| 25 | FES | 1.42221148 |
| 26 | CASK | 1.40888348 |
| 27 | MAP4K1 | 1.40185381 |
| 28 | MAP2K3 | 1.38414397 |
| 29 | TIE1 | 1.37154234 |
| 30 | BCR | 1.33519639 |
| 31 | FGR | 1.25981028 |
| 32 | PBK | 1.25390618 |
| 33 | NLK | 1.21059312 |
| 34 | RIPK1 | 1.19949861 |
| 35 | CLK1 | 1.18955659 |
| 36 | BMPR1B | 1.17932731 |
| 37 | BMPR2 | 1.16838452 |
| 38 | EPHA3 | 1.11589161 |
| 39 | MAP3K3 | 1.10773379 |
| 40 | JAK3 | 1.10388594 |
| 41 | WNK1 | 1.08184637 |
| 42 | FGFR2 | 1.06918733 |
| 43 | ITK | 1.05385389 |
| 44 | TNK2 | 1.04584163 |
| 45 | TYK2 | 1.04114093 |
| 46 | GRK7 | 1.03682670 |
| 47 | IRAK1 | 0.99582078 |
| 48 | GRK6 | 0.98472164 |
| 49 | MAPK15 | 0.96410307 |
| 50 | ADRBK2 | 0.95053473 |
| 51 | JAK1 | 0.93968935 |
| 52 | PRKCH | 0.92266359 |
| 53 | TEC | 0.90304026 |
| 54 | LCK | 0.89798917 |
| 55 | MET | 0.88508302 |
| 56 | MAPK12 | 0.88187065 |
| 57 | PRKCQ | 0.87970358 |
| 58 | CSF1R | 0.87810525 |
| 59 | CSK | 0.87517764 |
| 60 | SGK2 | 0.87233425 |
| 61 | TAOK1 | 0.86089725 |
| 62 | EPHA4 | 0.85689023 |
| 63 | MAP3K12 | 0.85175848 |
| 64 | ERN1 | 0.83263586 |
| 65 | NTRK1 | 0.80015667 |
| 66 | MAPK7 | 0.79923607 |
| 67 | UHMK1 | 0.79729369 |
| 68 | CAMK2B | 0.79249606 |
| 69 | FGFR3 | 0.78310625 |
| 70 | BTK | 0.78078817 |
| 71 | SIK2 | 0.77380063 |
| 72 | TAOK2 | 0.75807108 |
| 73 | CHUK | 0.75627857 |
| 74 | MATK | 0.75347115 |
| 75 | BLK | 0.75156235 |
| 76 | PRKCE | 0.74875254 |
| 77 | HIPK2 | 0.72687087 |
| 78 | SGK494 | 0.72466711 |
| 79 | SGK223 | 0.72466711 |
| 80 | TRPM7 | 0.71818283 |
| 81 | SYK | 0.71585733 |
| 82 | HCK | 0.71543362 |
| 83 | CAMK2D | 0.71369031 |
| 84 | PRKD2 | 0.71285608 |
| 85 | CSNK1A1L | 0.70283310 |
| 86 | WNK4 | 0.69774367 |
| 87 | MARK3 | 0.68889371 |
| 88 | ROCK2 | 0.67578063 |
| 89 | FYN | 0.66062028 |
| 90 | CDK5 | 0.63763613 |
| 91 | CSNK1G3 | 0.62213840 |
| 92 | SGK3 | 0.61646432 |
| 93 | PDPK1 | 0.61602437 |
| 94 | TYRO3 | 0.61296388 |
| 95 | TGFBR2 | 0.60141880 |
| 96 | PIK3CG | 0.59796329 |
| 97 | MAP3K5 | 0.58722350 |
| 98 | PDK1 | 0.57838481 |
| 99 | IRAK3 | 0.57380604 |
| 100 | PIM1 | 0.57082067 |
| 101 | JAK2 | 0.56436369 |
| 102 | RPS6KA5 | 0.56015211 |
| 103 | MAP3K11 | 0.55828404 |
| 104 | CAMKK2 | 0.54844838 |
| 105 | MAPK4 | 0.53791016 |
| 106 | NTRK2 | 0.53750241 |
| 107 | STK11 | 0.53139555 |
| 108 | BMX | 0.52682873 |
| 109 | CAMKK1 | 0.52366617 |
| 110 | BRD4 | 0.52043619 |
| 111 | MAP3K1 | 0.51991270 |
| 112 | DMPK | 0.51923816 |
| 113 | MARK2 | 0.51917326 |
| 114 | CAMK2G | 0.51749268 |
| 115 | KSR2 | 0.51170074 |
| 116 | LYN | 0.51163775 |
| 117 | STK10 | 0.51052143 |
| 118 | PTK2B | 0.49911461 |
| 119 | YES1 | 0.49665968 |
| 120 | IRAK2 | 0.49520026 |
| 121 | CAMK4 | 0.49060199 |
| 122 | CAMK2A | 0.48387741 |
| 123 | CDC42BPA | 0.48356816 |
| 124 | MAP2K2 | 0.47877579 |
| 125 | DYRK1A | 0.47671705 |
| 126 | PDGFRB | 0.47442989 |
| 127 | ABL1 | 0.47211135 |
| 128 | PAK6 | 0.46493397 |
| 129 | FGFR4 | 0.45492199 |
| 130 | CSNK1G1 | 0.44415553 |
| 131 | NUAK1 | 0.43856545 |
| 132 | MAP3K7 | 0.43527046 |
| 133 | MOS | 0.42702941 |
| 134 | DAPK2 | 0.42149177 |
| 135 | NTRK3 | 0.40193616 |
| 136 | EGFR | 0.40030511 |
| 137 | STK38 | 0.38072708 |
| 138 | ERBB3 | 0.36972165 |
| 139 | MARK1 | 0.35673242 |
| 140 | DYRK1B | 0.31669283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malaria_Homo sapiens_hsa05144 | 2.03164940 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91988120 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 1.90795664 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.87399084 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85218621 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85159049 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.84062752 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76648834 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71086279 |
| 10 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.69899153 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65651583 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50664270 |
| 13 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.48511921 |
| 14 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46281060 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45318707 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42944016 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41122755 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39907220 |
| 19 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.39136259 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.38871052 |
| 21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37464572 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32052056 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28972030 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28378225 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27814477 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27631891 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26878475 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26040653 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.24269702 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23725305 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.22914888 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21122540 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19552274 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.19201954 |
| 35 | * Morphine addiction_Homo sapiens_hsa05032 | 1.15122711 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.15055451 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13817664 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.12929371 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12757504 |
| 40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.11703281 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11281708 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08985418 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08580488 |
| 44 | GABAergic synapse_Homo sapiens_hsa04727 | 1.07759215 |
| 45 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.05135954 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03827463 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03333650 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01832938 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01826846 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.98713767 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98706496 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98524616 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 0.97659186 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.96940790 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96904120 |
| 56 | Circadian entrainment_Homo sapiens_hsa04713 | 0.91523509 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90981410 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.89529160 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88516902 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86479844 |
| 61 | Long-term depression_Homo sapiens_hsa04730 | 0.85996011 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.85750267 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84837068 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84344977 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83935089 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83401264 |
| 67 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82247836 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.80799018 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.80152442 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79286710 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78436331 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78076835 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.77056978 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76712161 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.75894207 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.75499947 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.74111088 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73382630 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72305135 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71223757 |
| 81 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68803492 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.68330884 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.68313310 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67760794 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66771712 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65573507 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.65371581 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64624330 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64369251 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63700981 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62978195 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62402214 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62392054 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62016333 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60982968 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60240018 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59625721 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59522503 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58472405 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58400211 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57933486 |
| 102 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57923482 |
| 103 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56998174 |
| 104 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56918342 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56412284 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55230836 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54905486 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54546468 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.54454436 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53347741 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53014176 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51334904 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51271958 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50791774 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.50447007 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.50048426 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.49813314 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48979693 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48397042 |
| 120 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48083667 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47768643 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47442736 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46615668 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45417205 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45297613 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43013586 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41796601 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.41744967 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39013345 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37358836 |
| 131 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33386822 |

